Iacopo Fioroni

Induction chemotherapy backbone in frail patients with advanced NSCLC treated with chemotherapy plus pembrolizumab: a single institution retrospective audit of dose intensities from modified regimens.

Immunotherapy for Metastatic Non-Small Cell Lung Cancer: Therapeutic Advances and Biomarkers

Prognostic clinical factors in patients affected by non-small-cell lung cancer receiving Nivolumab

Radiotherapy and Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitors in Renal Cancer

Rechallenge with cetuximab + irinotecan in 3rd-line in RAS and BRAF wild-type metastatic colorectal cancer (mCRC) patients with acquired resistance to 1st-line cetuximab+irinotecan: The phase II CRICKET study by GONO.

Rechallenge with cetuximab (cet) + irinotecan (iri) in 3rd-line in RAS and BRAF wt metastatic colorectal cancer (mCRC) patients (pts) with acquired resistance to 1st-line cet + iri: the phase II CRICKET study by GONO

Procalcitonin as diagnostic marker of infection in solid tumors patients with fever

Role of c-mesenchymal–epithelial transition pathway in gastric cancer

Emerging drugs for the treatment of bone metastasis

Procalcitonin as diagnostic marker in febrile cancer patients

The Potential Diagnostic Role of Procalcitonin for Bacteremia in a Large Cohort of Solid Cancer Patients

The potential diagnostic role of procalcitonin for bacteremia in a large cohort of solid cancer patients.